Ads
related to: sars-cov-2 virus treatment
Search results
Scientists argue over the origins of COVID-19 before U.S. Senate panel
New Hampshire Bulletin via Yahoo News· 2 days agoWASHINGTON – Scientists debated the origins of COVID-19 on Tuesday, trading barbs over whether the...
Bird Flu Pandemic Just “A Question Of When”, Says Ex-CDC Director
IFLScience· 4 days agoA former director of the Centers for Disease Control and Prevention (CDC) told a US cable news...
Fast, accurate, and cost-effective POC Covid-19 tests are set to revolutionise the testing market
Medical Device Network via Yahoo Finance· 3 days agoPoint-of-care (POC) SARS-CoV-2 tests, which can deliver results in a matter of minutes, could mark a...
Long COVID Risk Factors Revealed In Data From Nearly 5,000 People
IFLScience· 4 days agoLong COVID describes a chronic condition that is present for at least three months after an...
Could auto-antibodies be linked to severe COVID-19?
Medical Xpress· 1 day agoEven though COVID-19 manifests as a mild and short-lived disease in most people, some suffer extremely severe symptoms; in the worst cases, these patients die due to complications such as respiratory ...
Simple test for flu could improve diagnosis and surveillance
Medical Xpress· 2 days agoIt can also identify strains that resist antiviral treatment, and with further work, could...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 4 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
New study involving nearly 185,000 patients recommends strengthening immunity against COVID-19 in...
Medical Xpress· 2 days agoThe research, published in the journal Nature Communications, recommends administering additional doses of the vaccine among this risk population. Cancer patients are at increased risk of death ...
Xencor (NASDAQ:XNCR) Price Target Cut to $40.00 by Analysts at Raymond James
ETF DAILY NEWS· 6 days agoXencor (NASDAQ:XNCR – Free Report) had its target price lowered by Raymond James from $58.00 to $40.00 in a research report report published on Friday, Benzinga reports. The firm currently has ...
A new look at why old age is linked to severe, even fatal COVID
Medical Xpress· 6 days agoEver since the beginning of the pandemic in 2020, it has been abundantly clear that older adults are...